Patents Assigned to Centro de Investigación Biomédica en Red de Enfermedades
  • Patent number: 10526276
    Abstract: The present invention relates to a group of compounds with a structural nucleus derived from phenylacetamide, having the following formula (I): that can modulate the DREAM neuronal calcium sensor. Consequently, the present invention also relates to the use of these compounds for the treatment or prevention of disorders or diseases in which DREAM levels are above or below physiologically normal levels.
    Type: Grant
    Filed: December 17, 2015
    Date of Patent: January 7, 2020
    Assignees: CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS, CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES NEURODEGENERATIVAS (CIBERNED), UNIVERSIDAD AUTÓNOMA DE MADRID
    Inventors: Marta Gutiérrez Rodríguez, Pilar Cercos Pita, María Rosario Herranz Herranz, María Teresa García López, María Carmen Valenzuela Miranda, José Ramón Naranjo Orovio, Britt Mellstrom, Paz González Pérez, María Mercedes Martín Martínez, José Manuel Dopazo Santos
  • Publication number: 20180346996
    Abstract: The present invention relates in general to the field of colorectal cancer detection, and more particularly, to plasma microRNAs for the detection of early colorectal cancer.
    Type: Application
    Filed: June 28, 2018
    Publication date: December 6, 2018
    Applicants: CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES HEPÁTICAS Y DIGESTIVAS, HOSPITAL CLINIC DE BARCELONA
    Inventors: Meritxell Gironella COS, Juan José LOZANO SALVATELLA, Antoni Castells GARANGOU, Maria Dolores GIRALDEZ JIMÉNEZ
  • Patent number: 9297034
    Abstract: The present invention relates to a method for the detection and/or quantification of Streptococcus pneumoniae, a Gram-positive bacteria that is an important human pathogen, in an isolated biological sample, through magneto-amperometric biosensors, comprising detecting fragments of lytA gene of the microorganism, amplified through PCR, preferably asymmetric PCR or direct asymmetric PCR, by hybridization thereof to a specific probe fully complementary to a region of the amplified fragment. Furthermore, the present invention also relates to the use of primers SEQ ID NO: 3 and 4 together with probes SEQ ID NO: 1 and/or SEQ ID NO: 2 to perform the detection. The biosensor developed to detect S. pneumoniae can be applied to different types of clinical samples from patients infected with this bacterium or other related bacteria. Preferably the clinical sample is an isolated biological fluid such as blood, cerebrospinal fluid, saliva or urine.
    Type: Grant
    Filed: December 16, 2010
    Date of Patent: March 29, 2016
    Assignees: Consejo Superior de Investigaciones Científicas (CSIC, Centro de Investigación Biomédica en Red de Enfermedades, Universidad Complutense de Madrid
    Inventors: Ernesto Garcia Lopez, Pedro Garcia Gonzalez, José Luis Garcia Lopez, Susana Campuzano Ruiz, María Morales Areizaga, María Carmen Ardanuy Tisaire, José Manuel Pingarrón Carrazón, María Pedrero Muñoz
  • Publication number: 20160042514
    Abstract: The method comprising acquiring and analysing by computer means image information of video sequences of two or more dimensions obtained from contrast-enhanced signals, for example ultrasound, coherence tomography, fluorescence images, or Magnetic Resonance Imaging, of a body part or tissue, for example of an organ, of a living subject; detecting events from said information of video sequences; selecting a Region of Interest of said body part or tissue; computing a first graph representative of a local vascular network of said image information of video sequences in which the edges of the graph are estimated by the temporal relationship among spatially remote signals of said image information of video sequences within a set of video sequences; and using said graph for assessment of vascular networks.
    Type: Application
    Filed: March 20, 2014
    Publication date: February 11, 2016
    Applicants: EXPERT YMAGING, SL, HOSPITAL CLINIC I PROVINCIAL DE BARCELONA, UNIVERSITAT DE BARCELONA, FUNDACIÓ CLINIC PER A LA RECERCA BIOMÈDICA (FCRB), CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES HEPÁTICAS Y DIGESTIVA
    Inventors: Ivan AMAT ROLDAN, Jaime BOSCH GENOVER, Annalisa BERZIGOTTI, Maria Rosa GILABERT SOLÉ
  • Publication number: 20130052641
    Abstract: The present invention relates to a method for the detection and/or quantification of Streptococcus pneumoniae, a Gram-positive bacteria that is an important human pathogen, in an isolated biological sample, through magneto-amperometric biosensors, comprising detecting fragments of lytA gene of said microorganism, amplified through PCR, preferably asymmetric PCR or direct asymmetric PCR, by means of the hybridization thereof to a specific probe fully complementary to a region of said amplified fragment. Furthermore, the present invention also relates to the use of primers SEQ ID NO: 3 and 4 together with probes SEQ ID NO: 1 and/or SEQ ID NO: 2 to perform said detection. The biosensor developed to detect S. pneumoniae can be applied to different types of clinical samples from patients infected with this bacterium or other related bacteria. Preferably the clinical sample is an isolated biological fluid such as blood, cerebrospinal fluid, saliva or urine.
    Type: Application
    Filed: December 16, 2010
    Publication date: February 28, 2013
    Applicants: CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC), CENTRO DE INVESTIGACION BIOMEDICA EN RED DE ENFERMEDADES RESPIRATORIAS (CIBERES), UNIVERSIDAD COMPLUTENSE DE MADRID
    Inventors: Ernesto Garcia Lopez, Pedro Garcia Gonzalez, José Luis Garcia Lopez, Susana Campuzano Ruiz, María Morales Areizaga, María Carmen Ardanuy Tisaire, José Manuel Pingarrón Carrazón, María Pedrero Muñoz